Compare NWBI & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NWBI | RXRX |
|---|---|---|
| Founded | 1896 | 2013 |
| Country | United States | United States |
| Employees | 2233 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | 2009 | 2021 |
| Metric | NWBI | RXRX |
|---|---|---|
| Price | $14.18 | $3.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $14.50 | $7.50 |
| AVG Volume (30 Days) | 864.9K | ★ 17.1M |
| Earning Date | 04-27-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.82% | N/A |
| EPS Growth | ★ 16.46 | 14.79 |
| EPS | ★ 0.34 | N/A |
| Revenue | N/A | ★ $74,681,000.00 |
| Revenue This Year | $6.29 | $12.11 |
| Revenue Next Year | $5.06 | $82.52 |
| P/E Ratio | $41.68 | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $11.25 | $2.77 |
| 52 Week High | $14.26 | $7.18 |
| Indicator | NWBI | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 58.46 | 47.43 |
| Support Level | $11.81 | $2.85 |
| Resistance Level | $14.26 | $5.12 |
| Average True Range (ATR) | 0.25 | 0.29 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 91.43 | 35.83 |
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution, offering personal and commercial banking solutions, business services, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and Commercial Banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Commercial Banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.